Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.B. Prusiner.
Shattuck lecture-neurodegenerative diseases and prions.
N Engl J Med, 344 (2001), pp. 1516-1526
[3.]
L. Fishbein.
Transmissible spongiform encephalopathies, hypotheses and food safety: An overview.
Sci Total Environ, 217 (1998), pp. 71-82
[5.]
J.D. Cooper, S.M. Bird, D. de Angelis.
Prevalence of detectable abnormal prion protein in persons incubating vCJD: Plausible incubation periods and cautious inference.
J Epidemiol Biostat, 5 (2000), pp. 209-219
[6.]
A. Alperovitch, I. Zerr, M. Pocchiari, E. Mitrova, C.J. De Pedro, I. Hegyi, et al.
Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease.
Lancet, 353 (1999), pp. 1673-1674
[7.]
A.F. Hill, M. Desbruslais, S. Joiner, K.C. Sidle, I. Gowland, J. Collinge, et al.
The same prion strain causes vCJD and BSE.
Nature, 389 (1997), pp. 448-450
[8.]
D. Bateman, D. Hilton, S. Love, M. Zeidler, J. Beck, J. Collinge.
Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK.
Lancet, 346 (1995), pp. 1155-1156
[9.]
T.C. Britton, S. Al Sarraj, C. Shaw, T. Campbell, J. Collinge.
Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK.
Lancet, 346 (1995), pp. 1155
[10.]
R.G. Will, J.W. Ironside, M. Zeidler, S.N. Cousens, K. Estibeiro, A. Alperovitch, et al.
A new variant of Creutzfeldt-Jakob disease in the UK.
Lancet, 347 (1996), pp. 921-925
[11.]
C.A. McLean, J.W. Ironside, M.P. Alpers, P.W. Brown, L. Cervenakova, R.M. Anderson, et al.
Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: Evidence for strain of agent predominating over genotype of host.
Brain Pathol, 8 (1998), pp. 429-437
[12.]
J.P. Deslys, C.I. Lasmezas, N. Streichenberger, A. Hill, J. Collinge, D. Dormont, et al.
New variant Creutzfeldt-Jakob disease in France.
Lancet, 349 (1997), pp. 30-31
[15.]
N. Kopp, N. Streichenberger, J.P. Deslys, J.L. Laplanche, G. Chazot.
Creutzfeldt-Jakob disease in a 52-year-old woman with florid plaques.
Lancet, 348 (1996), pp. 1239-1240
[16.]
J. Verdrager.
New variant Creutzfeldt-Jakob disease and bovine pituitary growth hormone.
Lancet, 351 (1998), pp. 112-113
[17.]
S. Collins, M.G. Law, A. Fletcher, A. Boyd, J. Kaldor, C.L. Masters.
Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: A case-control study.
Lancet, 353 (1999), pp. 693-697
[18.]
T. Weber, H. Tumani, B. Holdorff, J. Collinge, M. Palmer, H.A. Kretzschmar, et al.
Transmission of Creutzfeldt-Jakob disease by handling of duramater.
Lancet, 341 (1993), pp. 123-124
[19.]
D.N. Berger JR.
Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers.
Neurology, 43 (1993), pp. 205-206
[20.]
D.M. Taylor, J.R. Fraser.
The potential risk of transmitting vCJD through surgery.
J Hosp Infect, 44 (2000), pp. 318-319
[21.]
W.B. Matthews.
Transmission of Creutzfeld-Jakob disease.
Lancet, 343 (1994), pp. 1575-1576
[22.]
P.T. Davies, S. Jahfar, I.T. Ferguson, O. Windl.
disease in individual occupationally exposed to BSE.
Lancet, 342 (1993), pp. 680
[23.]
J.W. Ironside, M.W. Head, J.E. Bell, L. McCardle, R.G. Will.
Laboratory diagnosis of variant Creutzfeldt-Jakob disease.
Histopathology, 37 (2000), pp. 1-9
[24.]
W.H. Nailon, J.W. Ironside.
Variant Creutzfeldt-Jakob disease: Immunocytochemical studies and image analysis.
Microsc Res Tech, 50 (2000), pp. 2-9
[25.]
A. Dervaux, S. Vicart, F. Lopes, M.H. Le Borgne.
Psychiatric features of vCJD similar in France and UK.
Br J Psychiatry, 178 (2001), pp. 276
[26.]
S. Poser, I. Zerr, A. Schroeter, M. Otto, A. Giese, B.J. Steinhoff.
Clinical and differential diagnosis of Creutzfeldt-Jakob disease.
Arch Virol Suppl, 16 (2000), pp. 153-159
[27.]
C. Oppenheim, J.P. Brandel, J.J. Hauw, J.P. Deslys, B. Fontaine.
MRI and the second French case of vCJD.
Lancet, 356 (2000), pp. 253-254
[28.]
S. Collins, A. Boyd, A. Fletcher, M.F. Gonzales, C.A. McLean, C.L. Masters.
Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease.
J Clin Neurosci, 7 (2000), pp. 195-202
[29.]
M. Zeidler, R.J. Sellar, D.A. Collie, R. Knight, G. Stewart, M.A. Macleod, et al.
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease.
Lancet, 355 (2000), pp. 1412-1418
[30.]
P. Demaerel, A.L. Baert, L. Vanopdenbosch, W. Robberecht, R. Dom.
Diffusionweighted magnetic resonance imaging in Creutzfeldt-Jakob disease.
Lancet, 349 (1997), pp. 847-848
[31.]
T. Kawashima, H. Furukawa, K. Doh-ura, T. Iwaki.
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.
Lancet, 350 (1997), pp. 68-69
[32.]
D.J. Evans.
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.
Lancet, 349 (1997), pp. 1323
[33.]
S.C. Arya.
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.
Lancet, 349 (1997), pp. 1322-1323
[34.]
A.F. Hill, M. Zeidler, J. Ironside, J. Collinge.
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.
Lancet, 349 (1997), pp. 99-100
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
